https://www.selleckchem.com/pr....oducts/nvp-dky709.ht
To investigate whether routine cervical screening using human papillomavirus (HPV) and cytology co-testing effectively identifies women with endometrial (EC) or ovarian (OvC) cancer. In 2003, Kaiser Permanente Northern California implemented triennial co-testing in women aged ≥30years. Index screening results (n=2,385,729) were linked to subsequent EC (n=3434) and OvC (n=1113) diagnoses from January 1, 2003 to December 31, 2017. EC were categorized as type 1 or 2, and, selectively, EC and OvC diagnoses were stratified on whether symp
Like
Comment
Share
